Recent advances in smart stimuli-responsive biomaterials for bone therapeutics and regeneration


Recent advances in smart stimuli-responsive biomaterials for bone therapeutics and regeneration

Play all audios:


ABSTRACT Bone defects combined with tumors, infections, or other bone diseases are challenging in clinical practice. Autologous and allogeneic grafts are two main traditional remedies, but


they can cause a series of complications. To address this problem, researchers have constructed various implantable biomaterials. However, the original pathological microenvironment of bone


defects, such as residual tumors, severe infection, or other bone diseases, could further affect bone regeneration. Thus, the rational design of versatile biomaterials with integrated bone


therapy and regeneration functions is in great demand. Many strategies have been applied to fabricate smart stimuli-responsive materials for bone therapy and regeneration, with stimuli


related to external physical triggers or endogenous disease microenvironments or involving multiple integrated strategies. Typical external physical triggers include light irradiation,


electric and magnetic fields, ultrasound, and mechanical stimuli. These stimuli can transform the internal atomic packing arrangements of materials and affect cell fate, thus enhancing bone


tissue therapy and regeneration. In addition to the external stimuli-responsive strategy, some specific pathological microenvironments, such as excess reactive oxygen species and mild


acidity in tumors, specific pH reduction and enzymes secreted by bacteria in severe infection, and electronegative potential in bone defect sites, could be used as biochemical triggers to


activate bone disease therapy and bone regeneration. Herein, we summarize and discuss the rational construction of versatile biomaterials with bone therapeutic and regenerative functions.


The specific mechanisms, clinical applications, and existing limitations of the newly designed biomaterials are also clarified. SIMILAR CONTENT BEING VIEWED BY OTHERS ON THE ROAD TO SMART


BIOMATERIALS FOR BONE RESEARCH: DEFINITIONS, CONCEPTS, ADVANCES, AND OUTLOOK Article Open access 11 February 2021 REVIEW OF A NEW BONE TUMOR THERAPY STRATEGY BASED ON BIFUNCTIONAL


BIOMATERIALS Article Open access 16 March 2021 SELF-PROMOTED ELECTROACTIVE BIOMIMETIC MINERALIZED SCAFFOLDS FOR BACTERIA-INFECTED BONE REGENERATION Article Open access 31 October 2023


INTRODUCTION Tumors, severe infection, osteoporosis, osteonecrosis, and some congenital malformations can cause large bone defects, which remain challenging in clinical practice.1 Bone


defects induced by various causes are currently one of the principal causes of morbidity and disability, which decrease quality of life and endanger lives.2 The annual medical cost and lost


wages for individuals with musculoskeletal diseases reached $849 billion in 2004, which is 7.7% of the GDP of the United States.3 With the increasing number of patients in an aging society,


the total direct cost of patients with musculoskeletal disease increased by 117% between 2009 and 2011. Moreover, with increasing social demand, research and development costs are also


rising year by year. According to Food and Drug Administration data, the clinical development cost of products in phases I–III increased to $14.0 billion in 2020. Moreover, the market for


bone substitutes was estimated at over 2.3 billion US dollars in 2015, and this value was expected to exceed 3.6 billion US dollars from 2016 to 2022.4 The traditional treatments for bone


defects include autologous and allogenic grafts, which have many disadvantages, such as secondary injury, limited resources, the risk of infectious disease, and immunological rejection.5,6,7


Other treatment methods, including distraction osteogenesis, growth factor loading, electrical stimulation, Masquelet-induced membrane technique, and various combinations of these methods,


have also been developed in recent years.8,9 However, the tedious and arduous treatment period and numerous potential complications limit their clinical applications. Bone tissue engineering


(BTE) is a newly developed alternative approach that introduces an exogenous scaffold to encourage cells to grow and proliferate by providing regulatory growth factors.7,8,10,11 These


implantable scaffolds are required to match the properties of the original tissues, such as osteoinductivity, biocompatibility, osteoconductivity, and suitable mechanical strength.12,13


Various artificial implantable scaffolds, including metal, bioceramic, biopolymer, and composite implants, are manufactured for bone tissue regeneration or BTE applications.6,14,15,16


Although bone regeneration shows excellent promise,8 BTE still has some fatal problems, such as high cost, the potential tumorigenic risk of growth factors, and the inability to develop a


natural combination with the surrounding normal tissue.17 Moreover, implant fractures caused by inflammation, loosening, and osteolysis remain as challenges to be addressed.18 In addition,


residual tumor tissue and severe infection can lead to recurrence, metastasis, or sepsis, which can ultimately endanger life. Moreover, residual tumor tissue and infection promote the


release of inflammatory factors and activate osteoclasts, leading to the consumption of bone tissue and ultimately to the failure of bone regeneration.19 Hence, traditional resection and


reconstruction cannot solve the problem entirely due to the limited ability to achieve correct autoregeneration.6,20 In addition to surgical resection, other standard methods, such as


radiation therapy and chemotherapy, have low selectivity for tumor cells and high toxicity to normal cells, significantly limiting their clinical applications.21 Based on this, the rational


design and construction of versatile biomaterials with both disease therapy and bone regeneration functions are in great demand.22 In addition, various diseases have different specific


pathological microenvironments, such as excess reactive oxygen species (ROS) and specific mild acidity in tumors,23,24 specific pH reduction and enzymes secreted by bacteria in severe


infection,25,26,27 and electronegative potentials in bone defect sites.28 Based on these specific pathological features, researchers designed corresponding materials that can autonomously


respond to the specific environmental changes surrounding the lesion, thus activating bone disease therapy and bone defect regeneration. Such design strategies were defined as internal


microenvironment stimuli-responsive strategies in this review. In addition, external physical stimuli, such as light, magnetic fields, electricity, ultrasound, or appropriate mechanical


stimuli, can transform the internal atomic packing arrangements of materials, thus affecting cell fate and enhancing bone tissue therapy and regeneration.29,30 The design strategies


utilizing external physical stimuli were defined as external stimuli-responsive strategies in this review. Based on these concepts, a number of novel bifunctional materials with smart


stimuli-responsive therapeutic and regenerative abilities were developed,31,32 which could undergo reversible or irreversible transformations in physical performance or chemical structure in


response to external physical triggers (e.g., light irradiation, electric and magnetic fields, ultrasound, appropriate mechanical stimulus), endogenous disease microenvironments (e.g.,


overexpressed ROS, mild acidity, endogenous electric fields, specific ionic concentrations, secreted enzymes or specific immune environments), or a combination of the above (Fig. 1).22,33,34


The definition of “smart” here refers to the properties of biomaterials that can exert stimulating or inductive effects on tissues by responding to external or internal stimuli.3 Smart


on-demand stimuli-responsive biomaterials can maximize therapeutic efficacy and minimize undesirable side effects because they can rapidly detect and respond to the disease environment and


exert therapeutic effects while preserving physiologically healthy cells and tissues, thus improving patient quality of life.35,36 Recently, Montoya et al.37 proposed a redefinition of the


term “smart biomaterial” to recognize four levels of smartness: inert, active, responsive, and autonomous. Their well-organized review also divides smart biomaterials into two categories,


namely, smart biomaterials that respond to internal material properties (e.g., topography, mechanical properties, surface charge, and scaffold chemistry) and smart biomaterials that respond


to external stimuli (e.g., piezoelectricity, magnetism, pH, and enzymes). This classification would definitely facilitate the construction of new material systems and the exploration of


potential mechanisms. However, the range of external stimuli mentioned in this review might be too broad. Accordingly, we further subdivide it into two parts, namely, an internal


microenvironment stimuli-responsive strategy and an external stimuli-responsive strategy. Moreover, some well-constructed multifunctional biomaterials apply multiple strategies to achieve


outstanding effects. Thus, multiresponsive strategies are also addressed in our review. Smart stimuli-responsive biomaterials differ from traditional biomaterials due to their response to


stimulating/triggering factors in the surrounding environment (both external and internal).38,39 Thus, these novel biomaterials have received increasing attention from researchers in recent


years. Rapid progress in the manufacture of smart stimuli-responsive biomaterials has occurred in the past 5 years, from applying external stimulation to enhance bone regeneration and


therapeutic effects for smartly responses to variations in the internal microenvironment to rational synergistic therapy combining multiple strategies to improve therapeutic efficacy (Fig.


2). To summarize the previous research results and facilitate the further design and application of these novel smart stimuli-responsive materials for bone tissue therapy and regeneration in


the biomedical field, we summarize the recent advances in smart stimuli-responsive biomaterials in this field. In this review, we summarize the different stimuli-responsive strategies, both


external stimuli-responsive strategies and internal microenvironment stimuli-responsive strategies, and illustrate the classical biomedical applications for bone therapy and regeneration in


recent studies. We also compare the pros and cons of different strategies, and we discuss the current challenges and future prospects of these novel biomaterials. This knowledge might


assist in constructing versatile biomaterials in the future to meet the demand for bone regeneration in various environments. EXTERNAL STIMULI-RESPONSIVE BONE THERAPY AND REGENERATION


External stimuli such as light, magnetic fields, ultrasound, electrical stimulation, and appropriate mechanical stimuli can generate heat or stimulate bone cells to adhere, proliferate, and


differentiate in scaffolds, thus facilitating bone therapy and regeneration.8,29 In addition, most therapeutic biomaterials are constructed from nanomaterials with therapeutic functions,


such as magnetic nanoparticles (NPs) for magnetothermal ablation, photothermal nanoagents for photonic hyperthermia or drug nanocarriers for chemotherapy.22,40,41,42 Thus, integrating these


therapeutic NPs into bone regeneration scaffolds to construct smart stimuli-responsive scaffolds for bone therapy and regeneration is a promising and encouraging approach. A multitude of


studies have focused on this field and fabricated many novel biomaterials based on these strategies. Herein, we have summarized and illustrated various kinds of external stimuli-responsive


strategies in the following section. PHOTORESPONSIVE STRATEGY Radiation under an infrared laser can generate photophysical effects, subsequently changing intracellular behavior and


influencing the respiratory chain, which ultimately increases ATP regeneration in the mitochondrial membrane and heightens cell metabolism.43 These effects could facilitate angiogenesis and


bone regeneration.44 Therefore, the photoresponsive strategy is widely applied in both antitumor and antibacterial treatment due to easy synthesis and the presence of plentiful


photoresponsive functional nanosystems and components.22,45,46 Common photothermal agents include gold nanostructures, transition metal sulfides and oxides (e.g., CuFeSe2 nanocrystals, Fe3O4


NPs, and copper silicate microspheres), organic NPs, carbon-based NPs and graphene, MXenes, and single-elemental nanosheets (e.g., black phosphorus nanosheets (BPs)).47,48,49,50,51,52,53


Many studies have focused on this strategy and synthesized numerous multifunctional materials due to encouraging results. Tong et al.54 recently directly integrated BP nanosheets into


poly(lactic-co-glycolic acid) (PLGA) to construct a multifunctional scaffold (designated BPs@PLGA) for efficient osteogenesis. In this degradable biocomposite, BPs@PLGA containing 0.2 wt%


BPs exhibited highly efficient photoresponsive osteogenesis when covered by biological tissue. When exposed to near-infrared (NIR) light, the BPs@PLGA specimen can promote osteogenesis by


upregulating heat shock protein expression. Similarly, Wang et al.19 constructed BP-SrCl2/PLGA microspheres by directly loading BPs and SrCl2 into PLGA. NIR radiation can trigger the release


of Sr2+, which can ultimately improve bone regeneration, since the local temperature increase creates flaws in the PLGA shells. Similarly, to achieve radical tumor ablation and new bone


regeneration for osseous tumor therapy, nanohydroxyapatite/graphene oxide (nHA/GO) particles were used to functionalize chitosan (CS) scaffolds for their outstanding photothermal conversion


performance and bone-forming bioactivity (Fig. 3a).55 Under 808-nm NIR irradiation, the temperature was increased to 48 °C, which effectively ablated human osteosarcoma cells (Fig. 3b).


Moreover, NIR irradiation may enhance the BMP-2/Smad signaling pathway, which can significantly promote the osteogenesis of hBMSCs (Fig. 3c). In addition to the encouraging results in


osseous tumor therapy, a photoresponsive strategy was introduced to solve the difficult issue of surgical site infection. Zeng et al.56 fabricated a biocompatible polydopamine


(PDA)-IR820-daptomycin (DAP) coating in titanium (Ti) implants, which possesses the triple therapeutic functions of antibiotic, photodynamic, and photothermal activity (Fig. 4a). Laser


irradiation at 808 nm can stimulate PDA hyperthermia and release the singlet oxygen (1O2) generated by IR820, which can eradicate biofilms noninvasively. Furthermore, the successful


acceleration of glutathione oxidation, release of DAP, and destruction of the bacterial membrane can synergistically eliminate the target bacteria with an antibacterial efficiency of 97.2%


(Fig. 4b). Furthermore, the novel PDA coating increased the surface roughness, thus upregulating osteogenic-related gene expression and attaining a higher bone-implant contact level, which


ultimately enhanced the bone regeneration ability (Fig. 4c, d). In addition to the encouraging results of the photoresponsive biomaterials described above, several issues still need to be


settled in the future. The low tissue penetration depth of light severely limits the ability of photothermal conversion, thus ultimately impeding deep tissue regeneration in the body. Thus,


the exploration of other controllable and noninvasive physical triggers to improve tissue penetration capability is desperately needed in the future to accelerate the clinical translation of


these novel strategies.22,43 MAGNETIC FIELD-RESPONSIVE STRATEGY Magnetic NPs, usually referred to as Fe3O4 NPs, can serve as therapeutic agents for magnetic hyperthermia, not only


generating heat under exposure to an external magnetic field but also improving the osteogenic differentiation ability, thus making this technology highly promising in bone tissue


regenerative applications.22,57,58 After exposure to irradiation with an external magnetic field, the heat produced by magnetic Fe3O4 NPs can elevate the temperature to 42 °C–45 °C, which


can damage or even kill cancerous cells due to hemorrhage or vascular occlusion while remaining harmless to the normal surrounding tissues.24,59 In addition, magnetic hyperthermia might also


contribute to inducing better osteogenic differentiation. Nevertheless, the potential mechanisms remain unclear. Some researchers hold the view that hyperthermia could influence bone


metabolism by enhancing the blood supply.57 Other researchers believe that hyperthermia improves osteogenic expression by enhancing mitochondrial activity and accelerating the expression of


bone-related genes.60 The related detailed mechanisms for the osteogenic stimulation derived from magnetic hyperthermia still need to be further elucidated. Compared to the photoresponsive


strategy, magnetothermal therapy by an external alternating magnetic field has the advantage of high tissue penetration capability, which make it promising for treating lesions in deep


tissue, such as bone tumors. Moreover, magnetic field-responsive therapy has the advantages of noninvasiveness and high controllability, which are in high demand for bone tumor ablation and


local bone regeneration. Many researchers have exploited versatile multifunctional biomaterials using a magnetic field-responsive strategy, combining the functions of bone disease therapy


and bone tissue regeneration. Zhu et al.58 fabricated magnetic 10Fe5Ca MBG scaffolds (Fe3O4–CaO–SiO2–P2O5 system), which could produce heat upon exposure to an external alternating magnetic


field. In addition, osteoblast cell proliferation, alkaline phosphatase (ALP) activity, and osteogenic expression could also be enhanced because of the lower ion dissolution rate and the


possibility of maintaining a beneficial pH value. In the lower pH environment, drugs such as gentamicin were easily released, resulting in a corresponding therapeutic effect. With the


multifunctionality of magnetic hyperthermia, local drug delivery therapy, and bone regeneration, these synthetic magnetic scaffolds have high future potential in the treatment of bone


tumors. Similarly, Dong et al.24 integrated calcium peroxide (CaO2) and iron oxide (Fe3O4) NPs with an akermanite (AKT) scaffold (designated AKT-Fe3O4-CaO2) using a three-dimensional


printing (3DP) technique to combine magnetic hyperthermia and bone regeneration. The loaded Fe3O4 NPs not only served as triggers to initiate magnetic hyperthermia for quick temperature


elevation but also acted as nanocatalysts to initiate the Fenton reaction in tumor-oxidative therapy (Fig. 5a). In addition, the loaded CaO2 NPs can react to the acidic tumor environment and


subsequently produce H2O2, which could not only remedy the consumption of H2O2 via the Fenton reaction but also release Ca2+ ions to further induce bone regeneration. The incorporation of


nanocatalytic oxidative therapy and magnetic hyperthermia significantly restrained tumor growth compared to either single therapy (Fig. 5b). In addition, the continuous release of Ca2+


within the scaffolds obviously improved osteogenesis, as shown by both micro-CT reconstruction and quantitative analysis of Van Gieson’s (VG) staining techniques (Fig. 5c, d). Similarly, Yan


et al.61 constructed an injectable magnetic bone cement (α-tricalcium phosphate (α-TCP)/CS/Fe3O4/GO, αCFG) by loading Fe3O4/GO nanocomposites into α-TCP/calcium sulfate biphasic bone


cement. The αCFG bone cement with 10 wt % Fe3O4/GO content was the most rigid and showed remarkable magnetothermal performance. Bone regeneration ability might also be enhanced by promoting


the attachment, proliferation, and osteogenic differentiation of rBMSCs. Although all the studies related to magnetic field-triggered bone therapy and regeneration are at a preliminary


stage, the encouraging results are capturing increasing attention. Further research may concentrate on uniform magnetic heating and methods for reducing the risk of thermal damage to


surrounding normal tissues.61 ULTRASOUND-RESPONSIVE STRATEGY In addition to photodynamic therapy (PDT), sonodynamic therapy (SDT) is a highly promising noninvasive technique for eradicating


tumor cells. In contrast to PDT, SDT is initiated by ultrasound with a tissue penetration depth of over 10 cm, which has been widely applied in clinical practice for several years in


ablating deep-seated tumors.62 In addition to tumor ablation, ultrasound was proven to enhance bone regeneration since it could enhance the mRNA level of vascular endothelial growth factor A


(VEGF-A) and stimulate cartilage cell proliferation, thus accelerating the maturation of newly formed bone and expediting cell mineralization.63,64 With in-depth research, this technique


was extended to the infection field for the clinical treatment of bone defects and severe bacterial infection.27,31,65 Crasto et al.66 fabricated novel liposome-rhBMP-2 nanocomplexes that


can release rhBMP-2 after exposure to nonthermogenic clinical diagnostic ultrasound. After implantation into the hindleg muscles, the liposome-rhBMP-2 nanocomplexes induce local bone


formation only after ultrasound exposure. Moreover, further research showed that rhBMP-2 release behavior varied with the duration of exposure and applied ultrasound pressure. To achieve


better sonodynamic and photothermal ability, Su et al.31 modified Ti implants through sulfur (S) doping to create an oxygen deficiency (Ti-S-TiO2-_x_), endowing this implant with remarkable


sonodynamic and photothermal ability (Fig. 6a). Without an external antibacterial coating, the novel Ti implant can reach an antibacterial efficiency of up to 99.995% against _Staphylococcus


aureus_ under 15 min of ultrasound and NIR light exposure (Fig. 6b–d). After combined therapy, the severe bone infection was successfully treated, and the osseointegration was improved


(Fig. 6e, f). Similar to the photoresponsive strategy, this ultrasound-responsive strategy is noninvasive with high controllability. Moreover, compared to traditional laser exposure, this


unique method has high tissue penetration capability, which makes it feasible for the therapy of deep-seated diseases. ELECTRORESPONSIVE STRATEGY Electrical stimulation has been demonstrated


to accelerate bone regeneration and maintain bone marrow mesenchymal stem cell (BMSC) stemness both in animal experiments and in clinical practice.67,68,69,70 Electrical stimulation


resulted in significant new bone formation because mesenchymal stem cell proliferation and differentiation were stimulated.71 This underlying mechanism contributes to upregulating bone


morphogenetic proteins under electrical stimulation, thus ultimately stimulating the calcium–calmodulin pathway, transforming growth factor-β (TGF-β) and other cytokines.67,68,72 Loading


electroactive materials, such as carbon nanotubes, metal, graphene, inorganic electroactive materials, and conductive polymers, is a direct way to deliver and respond to localized electrical


stimulation and thus will better regulate cellular activities and achieve better regeneration effects.73 Among all these electroactive biomaterials, conducting polymers, such as polypyrrole


(PPy), polyaniline (PANI), and poly(3,4-ethylenedioxythiophene), have conductivities similar to those of metals and inorganic semiconductor materials. They also have the advantages of good


biocompatibility and ease of synthesis.67,74,75,76 Thus, these kinds of conducting polymers have been widely applied in biomedical tissue engineering field.73 A multitude of multifunctional


materials that utilize this strategy to enhance osteogenesis expression were fabricated recently. Zhou et al.77 integrated PPy-PDA NPs with HA NPs using a layer-by-layer pulse


electrodeposition (LBL-PED) method. After that, the PPy-PDA-HA film was uniformly coated on the Ti surface to fabricate an osteoinductive, cell affinitive, and electroactive porous Ti


scaffold (Fig. 7a, b). When electrical stimulation was applied, the conductive polymer activated the Ca2+ channel of the cell membrane, thus facilitating extracellular Ca2+ entry into cells


and subsequently activating the Ca2+ signal transduction pathway. All these changes upregulated the expression of related genes. Ultimately, with the combined effect of HA and electrical


stimulation, osteogenic cell differentiation was promoted significantly (Fig. 7c–e), which illustrated its potential application as an implant for bone regeneration. In addition, to achieve


both antibiotic and osteogenic therapy, Zhu et al.76 recently applied Ag-loaded poly(amide-amine) dendrimer as the dopant in PANI fabrication and then coated Ti sheets with this


multifunctional coating. This PANI (PAMAM)@Ag layer coating combined with electrical stimulation synergistically enhanced osteogenesis expression. In addition, these unique coatings


exhibited remarkable antibacterial properties 1 000 times greater than those of pure Ti. Similarly, GdPO4·H2O nanobundles were used to functionalize PLGA and poly(3-hexylthiophene) (P3HT)


nanocomposites for electrically and magnetically responsive bone regeneration.73 The multifunctional GdPO4·H2O (7.0 wt%)/P3HT/PLGA composite could apparently increase calcium deposition and


ALP activity and upregulate the expression of related genes, thus enhancing osteogenic differentiation. Under electrical stimulation at 500 mV and 100 Hz, enhanced osteogenic differentiation


was observed. Moreover, the composites were traceable by X-ray and MRI owing to the incorporation of GdPO4·H2O nanobundles. Therefore, this novel biomaterial, which exhibits favorable


electroactivity, biocompatibility, and traceability, may be widely used to trace bone fixing materials and bone implants, providing a noninvasive method to observe implants. Despite the


encouraging effect of electrical stimulation on osteogenesis, certain issues still need to be settled before large-scale clinical application. The long-term cytotoxicity, biocompatibility,


and biodegradability of conductive scaffolds in vivo need to be further researched due to their long-term presence in vivo. We believe that conductive biomaterials will definitely become new


tissue engineering materials with great potential in the future. PIEZOELECTRICITY-RESPONSIVE STRATEGY Natural living bone tissue has bioelectrical properties, which play a critical role in


bone development.75,78 Piezoelectricity is defined as the phenomenon of transforming mechanical energy into electrical energy.78 Under physiological conditions, bone can generate electrical


signals when stressed by mechanical stimuli. These electrical signals can ultimately promote bone growth and remodeling.79 This unique phenomenon was observed by researchers and innovatively


applied in developing novel biomaterials. These newly developed biomaterials were defined as piezoelectric materials, which are a class of smart mechanoelectrical transducers that can


generate electrical signals under stress.80 It has been proven that piezoelectricity can regulate cell function and benefit the proliferation and osteogenic differentiation of stem cells.


Therefore, piezoelectric biomaterials are gradually attracting attention in the field of bone healing and BTE.81,82 Representative piezoelectric biomaterials, including piezo-bioceramics


(e.g., barium titanate (BaTiO3), magnesium silicate, zinc oxide) and some piezo-biopolymers (e.g., polyvinylidene fluoride, polyhydroxybutyrate, etc.), have been widely applied in biomedical


fields.83,84 On the basis of previous studies on piezoelectric materials, attaching piezoelectric materials to enhance piezoelectric properties has become an effective method in BTE


applications. To achieve a better bone regeneration effect, Tang et al.85 fabricated HA/BaTiO3 composite materials via slip casting. Subsequent polarization endowed the composite materials


with piezoelectric properties. After being subjected to cycle loading, the piezoelectric effect of BaTiO3 could facilitate the growth of osteoblasts and promote interaction with HA. This


rational design would provide a new method for bone defect regeneration. Contemporaneously, Bai et al.86 utilized this strategy in classic guided bone regeneration therapy to address the


limitation of insufficient osteoinductivity in currently available barrier membranes. The flexible nanocomposite membrane was fabricated by homogeneously distributing piezoelectric BaTiO3


NPs into a poly(vinylidene fluoridetrifluoroethylene) matrix. This unique technology achieved higher osteoinductivity and induced earlier neovascularization. After implantation with DBB


Bio-Oss® granules, mature bone structure formation was observed in critical-sized defect sites in rabbit mandibles treated with this novel design. Recently, Zhao et al.87 constructed a


periosteum structure/function-mimicking scaffold by rationally integrating poly(vinylidene fluoride-trifluoroethylene) (PVFT) and bioactive glass. The gradient structure of this rational


design includes a bioglass nanofibrous surface and a piezoelectric polymer layer for synergistically enhancing bone regeneration and periosteum formation in critical-sized bone defects. The


biomimetic scaffolds significantly improved the proliferation, migration, and osteogenic differentiation of mBMSCs, thus improving the formation of periosteum-like tissue and facilitating


bone regeneration in critical-sized defects. In addition, the negative pole of the PVFT layer can gather positive Ca2+ from bioactive glass, activating the CaSR of osteoblasts and ultimately


enhancing osteogenesis. This unique work presents a novel choice in applying biomimetic piezoelectric behavior for efficient bone regeneration in critical-sized bone defects. In general,


piezoelectricity-responsive biomaterials provide a natural physiological environment to regulate stem cell functions without extraneous drugs or growth factors, which could serve as an


innovation in bone regeneration and BTE. However, some limitations still remain to be addressed, such as the effects of densification, alkali volatilization, and high temperature in the


synthesis processing.84 In addition, the potential mechanisms and long-term biosafety and toxicity also remain to be explored in the future. There is still a long way to go before the


ultimate clinical translation of this novel strategy. MECHANICAL STIMULI-RESPONSIVE STRATEGY Osteocytes are mechanosensitive cells, and it has been widely proven that mechanical stimuli


could influence stem cell fate, including proliferation, migration, and differentiation.88,89 The proper mechanical stimulus has been proven to play a vital role in the metabolism and repair


of new bone formation.90 The lack of proper mechanical stimulus in new bone would reduce the expression of related osteogenic genes, thus impeding further new bone formation.91 However, the


improper magnitude of strains may lead to bone nonunion, even bone resorption.92 Numerous studies have focused on this phenomenon and attempted to explore its underlying mechanism. The


transcription factors YAP and TAZ were demonstrated to play significant roles in this process.93 YAP and TAZ can read a wide range of mechanical cues, such as extracellular matrix rigidity


and shear stress, and translate them into unique transcriptional programs with further essential regulatory roles.93 In addition, researchers found that continuous mechanical strain can


rapidly activate the PI3K/Akt signaling pathway and prompt maximum phosphorylation in a short duration. These transformations would induce the early differentiation of BMSCs toward an


osteogenic phenotype, thus regulating bone formation and improving bone regeneration even in the osteoporosis status.94 Furthermore, Eichholz et al.95 demonstrated that when affected by


fluid shear, osteocytes could secrete many distinct factors to promote hMSC recruitment and osteogenesis. This finding demonstrated great potential in improving bone regeneration in diseases


such as osteoporosis. Based on previous work, some researchers have started to explore incorporating this strategy into bone regeneration. Puwanun et al.96 used a standard see-saw rocker to


generate oscillatory fluid flow in vitro. After rocking at 45 cycles per min for 1 h per day and 5 days per week, bone differentiation and vascularization were significantly enhanced, which


would provide a simple and cost-effective therapy for bone regeneration in minor defects such as cleft palate. Similarly, Mohanraj et al.97 fabricated interesting mechanically activated


microcapsules to deliver specific medicine in response to a mechanically loaded environment for the smart regeneration of musculoskeletal tissues. These novel microcapsules release TGF-β3


upon mechanical stimulation, presenting a new perspective in tissue regeneration. However, all studies are still at the early stage of cell-level tests. Some challenges still exist before


mechanical stimuli can be used to promote bone tissue regeneration. An important issue to address in future studies is the optimization of mechanical parameters, such as the patterns,


amplitude, and frequency of mechanics, to fully facilitate new bone formation.98 Moreover, discovering a noninvasive method to apply mechanical stimuli in the regeneration process is


necessary before this method can be utilized in bone tissue regeneration.99 INTERNAL MICROENVIRONMENT STIMULI-RESPONSIVE BONE THERAPY AND REGENERATION Although outstanding therapeutic and


regenerative effects have been obtained with external stimuli-responsive materials, several disadvantages remain to be addressed. First, the maintenance of the effect requires the continuous


action of external stimuli, which is nearly impossible for the extended treatment period of bone therapy and regeneration. In addition, the intensity of external stimuli is generally


positively correlated with the therapeutic effect, but side effects also increase with stimulation intensity, thus significantly limiting the therapeutic effect. Finally, external stimuli


can be applied only after the disease is diagnosed, which causes a lag effect. Moreover, various diseases have different and specific pathological microenvironments, such as specific mild


acidity, excess ROS, electronegative potentials, specific ionic concentrations, particular immune environments, or enzyme release. All these specific pathological features can be applied to


design corresponding smart stimuli-responsive biomaterials for rapid-response bone therapy and regeneration. Different internal microenvironment stimuli-responsive strategies are summarized


and illustrated in the following section. OXIDATIVE SPECIES-RESPONSIVE STRATEGY ROS, such as peroxides, hydroxyl radicals, superoxide, singlet oxygen, and alpha-oxygen, are chemically


reactive chemical species containing oxygen.100,101 Overexpression of ROS may occur under various pathological conditions such as bodily injury, inflammation, neurodegenerative diseases,


solid tumors, and cardiovascular complications.102,103 Thus, excess endogenous ROS are often used as a trigger in stimuli-responsive bone therapy and regeneration. A multitude of recent


studies have focused on this strategy and synthesized multifunctional biomaterials applying this strategy. To fabricate scaffolds with selective tumor-killing and bacteria-killing effects,


an internal microenvironment-responsive composite scaffold was constructed by Wang et al. using a simple hydrothermal treatment.104 The butyrate-inserted Ni–Ti LDH film can selectively


suppress bacterial infection and tumor growth by exploiting the overexpression of H2O2 in tumor and infection microenvironments, thus releasing cytotoxic butyrate to inhibit metastasis and


enhance osteogenesis. Similarly, Ma et al.105 recently constructed optimized Fe-CaSiO3 composite scaffolds (30CS) using the 3DP technique (Fig. 8a). These novel scaffolds have high


mechanical strength and could function in both ROS tumor therapy and photothermal therapy (Fig. 8b, c). The consumption of ROS and the presence of CaSiO3 enhanced the proliferation and


differentiation of rBMSCs, thus enhancing osteogenesis in vivo (Fig. 8d). ROS are often generated in a multitude of pathological processes, such as solid tumors, severe infection,


cardiovascular complications, neurodegenerative diseases, and inflammatory diseases.102 However, ROS have the drawback of a small action range and short lifespan, which significantly hamper


the stimulus effect. In addition, ROS therapies have no specificity and will damage normal cells simultaneously. ACIDIC ENVIRONMENT-RESPONSIVE STRATEGY The microenvironment of the normal


human body is weakly alkaline. However, in some specific pathological conditions, such as chronic inflammation, infected or contaminated environments, and tumor environments, the humoral


environment may become mildly acidic.106,107,108,109 Accordingly, this microenvironmental characteristic has been exploited by some researchers to fabricate smart responsive biomaterials


with both therapeutic and regenerative functions.110 On this basis, a composite AKT-Fe3O4-CaO2 scaffold was fabricated by directly incorporating calcium peroxide (CaO2) and iron oxide


(Fe3O4) NPs into an AKT scaffold to promote simultaneous local magnetic hyperthermia and new bone formation in bone defects.24 The loaded CaO2 NPs can generate sufficient H2O2 in a mildly


acidic tumor environment. Therefore, H2O2 can be catalyzed by Fe3O4 NPs to produce hydroxyl radicals (·OH), which is an ROS with high antibacterial activity and cytotoxicity. Thus, ROS can


work synergistically with the therapeutic effects of magnetic hyperthermia and bone regeneration. Similarly, Deng et al.26 recently synthesized a unique “pDA-Ag-pDA” sandwich structure


coating by trapping silver NPs on the first pDA layer and then loading apatite on the second pDA layer. These novel coatings endowed the polyetheretherketone (PEEK) scaffold with


bacteria-triggered acidity-responsive ion-release behavior (Fig. 9a–c). In the acidic microenvironment of bacterial infection, Ag+ ions will be liberated immediately for bacterial killing


(Fig. 9d, f), and Ca2+ and PO43− ions will be rapidly delivered for osteogenesis enhancement (Fig. 9e, g). In addition to acute inflammation and tumors, some chronic diseases also manifest


mild acidity in the humoral environment, which may be harmful for subsequent bone tissue regeneration. Accordingly, several smart acidic environment-responsive biomaterials have been


constructed for bifunctional bone disease therapy and bone tissue regeneration. Osteoporosis is a worldwide chronic disease characterized by serious microarchitectural destruction of osseous


tissue and low bone mass. Recently, Lin et al.111 loaded sodium bicarbonate (NaHCO3) into tetracycline-functionalized nanoliposomes to construct a smart “nanosacrificial layer.” This smart


layer can target bone surfaces and respond to the local acidic environment caused by the abnormal activation of osteoclasts. When the constructed smart layer detects the external secreted


acidification from osteoclasts, the nanoliposomes can target the bone surface to form an alkaline protective layer, thus neutralizing the acid secretions of osteoclasts. By precisely


restraining the abnormal activation of osteoclasts, the sequential initiation of osteoclast apoptosis promotion will further promote the release of extracellular vesicles. Apoptosis-derived


extracellular vesicles contain receptor activator of nuclear factor-κ B (RANK), which further consumes RANK ligand (RANKL) in serum. This biological cascade could reverse bone destruction,


remodel the bone microenvironment, and promote osteogenesis, offering promise as a therapeutic for osteoporosis. Although this strategy can exert antibiotic and osteogenic effects, its


osteogenic ability still needs to be further enhanced. The issue of high local concentrations of antibiotics impeding further bone restoration also needs to be addressed in the future.


ENDOGENOUS ELECTRIC FIELD-RESPONSIVE STRATEGY External electric fields have been demonstrated to induce osteogenesis in numerous studies, which have been mentioned before. In addition,


endogenous electric fields naturally exist in vivo and play a vital role in bone generation, possibly regulating cell differentiation and proliferation and thus ultimately promoting bone


repair. Repairing the physiological electric microenvironment will facilitate bone damage regeneration.112 The endogenous electronegative potentials in bone defect sites were applied by Liu


et al.28 to fabricate electropositive ferroelectric BiFeO3 (BFO) nanofilms, which could establish built-in electric fields between the electropositive BFO nanofilms and the electronegative


bone defect walls, thus triggering implant osseointegration and biological healing (Fig. 10a–d). The sequential initiation of Ca2+ signaling, cell adhesion, and PI3K/AKT signaling in stem


cells may potentially promote osteogenesis (Fig. 10e). These nanocomposite membranes have the advantages of good applicability, remarkable flexibility, and simple fabrication, which offer a


well-suited and innovative strategy for bone repair. However, the long-term toxicity of the biomaterial and the long-term control of the stimulus intensity need to be examined in the future.


SPECIFIC IONIC CONCENTRATION-RESPONSIVE STRATEGY Ionic strength usually varies from one type of biological fluid to another.113 Specific ions will be released in a specific pathological


environment. Thus, the levels of various physiological electrolytes could be critical indicators for different diseases and can be applied in a strategy to activate bone regeneration.29


Krishna et al.114 used a polyelectrolyte of CS and HA (CS-HA) to make scaffolds and loaded them with bovine serum albumin to study the release properties in response to Ca2+. The extent of


drug release was studied in deionized water and aqueous solutions of Ca2+ and Na+, which showed rapid release of drugs increasing with the concentration of Ca2+. This novel smart material


seems to have the potential to trigger the release of drugs or growth factors at Ca2+-rich sites such as bone cracks and could thus facilitate the precise and rapid repair of fractured


bones. Tan et al.115 combined capped metal–organic frameworks (MOFs) and supramolecular pseudorotaxanes to fabricate mechanized Zr-MOFs. These novel biomaterials have the characteristics of


high drug encapsulation, good biocompatibility, and low cytotoxicity. The low pH and high Ca2+ concentration around bone tumor cells can trigger the release of 5-fluorouracil, thus


generating antitumor therapeutic effects in the specific pathological microenvironment. The regulation of Ca2+ and pH can also decrease adverse side effects and further promote bone


regeneration in vivo. Despite the relatively little research on ionic concentration-responsive materials, it is worth noting that electrolyte levels can be a crucial indicator for various


diseases.29 Therefore, combining this strategy with advances in material technology could definitely introduce more encouraging paradigms for precise bone therapy and bone regeneration in


the future. SPECIFIC ENZYME-RESPONSIVE STRATEGY Enzymes are highly specific and selective molecules that modulate numerous biological processes, such as protein expression and the formation


of cellular adhesions.29,116 Owing to the enzymes’ varied roles in different biological processes and their vital effects in the bioactivities of the skeletal system and in bone


disorders,113,117 research concerning smart enzyme-responsive biomaterials has attracted tremendous attention.29 For example, matrix metalloproteinases (MMPs) have been proven to be closely


associated with tumor invasion and metastasis.29,113 Other pathological conditions, such as osteoarthritis, osteoporosis, and rheumatoid arthritis, are also found to involve the


overexpression of MMPs in bone and cartilage cells.117,118,119 Furthermore, enzymes exhibit remarkable selectivity for their substrates, which allows biologically inspired chemical reactions


to be processed specifically and sophisticatedly.120 Based on these properties, several smart stimuli-responsive biomaterials have been exploited, applying dysregulated enzymes as a


biological trigger to achieve multiple functions, including diagnostics, drug targeting, drug release, and tissue regeneration.120,121,122,123,124,125 Ding et al.126 constructed a novel


enzyme-responsive platform (LBL@MSN-Ag NPs) by loading Ag NPs in mesoporous silica NPs (MSNs) and assembling poly-L-glutamic acid (PG) and polyallylamine hydrochloride on the resulting


particles by LBL assembly. In the presence of glutamyl endonuclease (V8 enzyme), which is secreted by _S. aureus_ in association with virulence, PG will be degraded since it is a homogeneous


polyamide made by an amide linkage. Therefore, the excess V8 enzyme in the environment of a bacterial infection would degrade PG and break down the film of LBL@MSN-Ag NPs, causing the


release of loaded Ag NPs and thereby achieving excellent antimicrobial efficacy. In addition, the assembled PG in the biomaterial is a synthetic polypeptide that has outstanding


biocompatibility and exhibits the potential to increase regeneration capacities. Thus, this rational smart on-demand enzyme-responsive platform can exhibit remarkable antimicrobial


properties while reducing Ag ion toxicity to healthy tissue and simultaneously enhancing regeneration. Similarly, to address the issues of the local delivery of growth factors to complex


bone fracture sites, Qi et al.127 recently constructed BMP-2 nanocapsules (denoted as n(BMP-2)) by the in situ polymerization of an MMP-cleavable peptide crosslinker and


2-(methacryloyloxy)ethyl phosphorylcholine monomer on the surface of BMP-2 (Fig. 11a). The tissue surrounding the bone fracture site will initiate the bone repair process. Thus, MMPs, which


are present only at low levels in normal tissues, are secreted at high levels into the extracellular matrix to degrade proteins. At this time, the crosslinker will be specifically degraded


by MMPs (Fig. 11b). This unique reaction will trigger the destruction of the polymer shells, thus releasing BMP-2 at the fracture sites to repair bone injury and enhance bone regeneration


(Fig. 11c–e). This rational design achieves outstanding osteogenic results and provides an alternative method for the rapid recovery of complex bone fractures. Despite the encouraging


results of this strategy, some troublesome problems remain to be solved in future research. First, since many similar enzyme families share overlapping substrates, more rational and specific


designs should be considered for a more precise response.120 Second, biocompatibility and long-term cytotoxicity should be evaluated thoroughly, thus facilitating eventual clinical


translation. Finally, various forms of enzyme dysregulation exist in different diseases. Thus, a comprehensive understanding of biological processes is still the basis of future research.


SPECIFIC IMMUNE ENVIRONMENT-RESPONSIVE STRATEGY The highly complicated immune system comprises the synergistic action of various immune cells that can produce various cytokines.128 The


implantation of various biomaterials and the progression of different diseases, such as bone fracture, bone infection, diabetes mellitus (DM), and even osteoporosis, can cause immune


responses and changes in the immune microenvironment.129,130,131 Variations in the immune state originate from the disease and ultimately affect the progression of the disease. Accordingly,


immunotherapy, which can trigger the body’s immune response to treat diseases with few side effects, has gained considerable attention in recent years, especially cancer immunotherapy.132 In


addition to disease therapy, the immune system plays a vital role in the process of bone tissue regeneration. After implantation, the immune system can recognize implant biomaterials as


“foreign” and initiate a fast response. Immune cells try to phagocytose or encapsulate the biomaterial, while inflammatory cytokines are secreted to assist this attack. Immune cells, such as


T lymphocytes, B lymphocytes, neutrophils, mast cells, dendritic cells (DCs), and macrophages, participate in the central control of the formation of the local bone microenvironment. By


regulating the expression of growth factors, inflammatory factors, chemokines, and other factors, immune cells regulate several processes of bone regeneration, such as cell recruitment,


osteogenic differentiation, osteoclastic differentiation, vascularization, and fibrosis.133,134,135,136 Among all immune cells, macrophages, which can be divided into M1 type and M2 type,


play vital roles in the wound healing process.128 M1 macrophages mainly regulate the osteoclastic process, while M2 macrophages are mainly involved in tissue repair during the middle and end


stages of bone regeneration,137 when they secrete a variety of cytokines, such as BMP-2 and VEGF, to ultimately induce bone formation.138 In addition to secreting various cytokines by


switching their polarization states, macrophages are responsible for the recruitment of other cells to the injury sites and for the phagocytosis of unwanted materials. Thus, macrophages play


the most important role during the process of bone tissue regeneration.128,139 In addition to these immune cells, various cytokines are essential parts of the immune system. For example,


interleukin (IL)-4 and TGF-β have been implicated in promoting osteoblast migration and proliferation. However, tumor necrosis factor (TNF)-α and IL-1β inhibit this process. Other


proinflammatory cytokines, such as TNF-α and IL-1, promote osteoclast cell activity and are involved in bone loss in osteoporosis.140,141 All immune cells and various cytokines construct the


bone immune microenvironment.137,142 The traditional strategy for tissue engineering was to design inert biomaterials to minimize the immune response.143 However, this effort failed owing


to insufficient nutrient supply and poor blood vessel invasion, which ultimately led to poor regenerative outcomes.128,136 Currently, many researchers have realized the benefit of the immune


response in tissue regeneration and found that the inflammatory response of immune cells to biomaterials is a vital factor in bone tissue regeneration.144,145 For example, polarization of


the anti-inflammatory M2 phenotype was proven to produce a favorable osteoimmune environment, thus enhancing osteogenesis.146 In addition, lymphocytes contribute to osteogenesis and bone


resorption. Activated T lymphocytes can express RANKL to promote the formation of osteoclasts and thus enhance bone resorption.147 However, B lymphocytes can also release interferon-γ to


inhibit the formation of osteoclasts, thus preventing excessive bone destruction in the physiological inflammatory response.148 Due to this recognition, numerous strategies have been


attempted to better utilize the immune system to improve the host-implant interaction. Developing a drug delivery system, exploiting novel immunomodulatory biomaterials, incorporating


inflammatory cytokines, and applying novel coatings are currently effective strategies to modulate the osteoimmunomodulatory properties of biomaterials, thereby shifting the immune


environment from osteoclastogenesis to osteogenesis.128,143,149,150,151,152,153,154 However, due to the highly complex and changeable properties of the immune environment, persistence and


gentle effects on lesions could not improve bone therapy and bone regeneration results. Therefore, smart stimuli-responsive biomaterials specific to various immune microenvironments have


gradually attracted increasing attention. Many chronic diseases involve long-term inflammatory bone destruction and are difficult to treat in the clinic. The development of smart specific


immune environment-responsive biomaterials has become promising for therapeutics in the past half-decade. Hu et al.155 fabricated a novel injectable microsphere that could serve as an


osteoimmunomodulatory biomaterial to modulate macrophages and create a healing-promoting environment in DM. The self-assembled microsphere incorporated heparin-modified gelatin nanofibers,


and IL-4 was linked to the nanofibrous heparin-modified gelatin microsphere (NHG-MS) to serve as an immunomodulatory cytokine. Under the proinflammatory microenvironment of DM, IL-4-loaded


NHG-MS can respond to proinflammatory M1 macrophages and switch them to the M2 phenotype, thus restoring the M2/M1 ratio to normal. This transformation can efficiently resolve inflammation,


enhance osteoblastic differentiation, and promote new bone formation. Hence, this novel injectable microsphere represents a promising strategy to improve bone healing and resolve


inflammation under DM. In addition to chronic diseases, smart specific immune environment-responsive biomaterials would also have outstanding efficiency for patients with acute inflammation


and tumors. Accordingly, drug-loaded double-layer sol–gel coatings were used to functionalize TiO2 nanotubes to modulate the switch from the M1 to the M2 phenotype.156 Under inflammatory


conditions, the M0 phenotype is polarized to M1 macrophages via the release of proinflammatory cytokines. Novel smart biomaterials will respond to excess M1 macrophages and release IL-4 to


directly regulate polarization from M1 to M2 macrophages, thus modulating the inflammatory response and promoting tissue repair. This novel strategy provides an idea for developing


functional biomaterials to enhance tissue regeneration and change the pathological state of inflammation in lesion sites. In addition to acute inflammation, the bone metastasis of cancer is


a major clinical problem, with the current treatment being severely destructive. To solve this difficult problem, He et al.157 recently fabricated a niobium carbide (Nb2C) MXene-modified


3D-printed biodegradable bioglass scaffold (BG@NbSiR) by loading an immune adjuvant (R837) to achieve checkpoint blockade immunotherapy. On the one hand, the loaded mesoporous Nb2C@Si NSs


provided outstanding photothermal conversion performance under NIR irradiation, enhancing tumor ablation capacity. Furthermore, BG scaffolds provided valuable elements (Ca, P, Si, etc.) and


sufficient space for bone regeneration. In particular, R837 offered an immune-activating vaccine-like function. In combination with the mass of tumor debris released by photonic hyperthermal


ablation, R837 promoted cytokine secretion and DC recruitment/maturation, thus ultimately activating an immune response to the tumor. By utilizing checkpoint blockade immunotherapy and


photonic hyperthermia, this BG@NbSiR scaffold could ablate primary tumors and activate the immune response, thus preventing tumor recurrence and metastasis. Although initiating bone therapy


and regeneration according to the site-specific immune environment of the lesion is a clever and effective strategy, several issues still need to be addressed. First, macrophages are the


primary source of mediators to initiate inflammation; thus, the unrestricted activation of macrophages may damage host immune homeostasis. Furthermore, improperly polarized macrophages at


the lesion site may also initiate osteoclast formation and subsequent osteolysis.136 Thus, the precise modulation of macrophage behaviors may be a necessary focus of future research before


applying specific immune environment-responsive strategies to enhance bone tissue therapy and regeneration. Second, additional research is necessary to determine the lowest concentration of


released IL-4 to induce macrophage polarization while maintaining host immune homeostasis.136,156 MULTIRESPONSIVE STRATEGIES FOR BONE THERAPEUTICS AND REGENERATION Combination therapy can


usually achieve better therapeutic outcomes than a single therapeutic modality owing to the synergistic effects of multiple therapeutic modalities.22,158 Similarly, multiresponsive


biomaterials, which are rationally designed with multiple modalities, provide platforms not only for bone disease therapy but also for bone regeneration. To address tumor-related bone


defects, a mesoporous BG/CS porous scaffold (MBCS) loaded with magnetic SrFe12O19 NPs was constructed by Lu et al.159 The magnetic field introduced by MBCS could promote the expression


levels of osteogenic-related genes and enhance bone formation by activating the BMP-2/Smad/Runx2 pathway. In addition, the loaded SrFe12O19 NPs could improve the photothermal conversion


capability and elevate the temperatures of tumors under exposure to NIR laser irradiation, which could cause apoptosis and ablation of residual tumors. Synergistic therapy combining a


magnetic field and NIR laser can exert an excellent effect on tumor ablation and bone regeneration and is highly promising in the treatment of tumor-related bone deficiency. In addition, to


address the challenging problem of infection after implantation, Su et al.31 used S-doping to create oxygen deficiencies on Ti implants, which endowed the implants with remarkable


photothermal and sonodynamic abilities. Under exposure to NIR light and ultrasound treatments, implants without external antibacterial coatings achieved an antibacterial efficiency of


99.995%. Moreover, improved osseointegration was observed after the successful treatment of bone infection by combination treatments. In addition to the novel combination of two kinds of


external stimulus-responsive strategies, some researchers have attempted to combine an external stimulus-responsive strategy with an internal microenvironment stimulus-responsive strategy


and have achieved outstanding results. For instance, Tan et al.115 designed multiresponsive “gated scaffolds” by combining supramolecular pseudorotaxanes and capped MOFs. The combination of


the low pH around bone tumor cells, the Ca2+ concentration due to osteolysis, and hyperthermia produced a synergistic effect in cancer therapy and bone regeneration. Coincidentally, the


AKT-Fe3O4-CaO2 scaffold was rationally designed by Dong et al.24 for multifunctional bone tumor therapy and bone tissue regeneration. On these smart stimuli-responsive platforms, Fe3O4 NPs


function as mediators for magnetic hyperthermia for quick temperature elevation under irradiation with an alternating magnetic field. In addition, CaO2 NPs were loaded into the smart


platform to produce sufficient H2O2 in the low-pH environment of osteolysis sites. The resulting production of H2O2 can trigger the Fenton reaction and finally induce tumor-oxidative therapy


(Fig. 5a). Another product in this reaction was Ca2+, which has a synergistic effect with magnetic hyperthermia in bone regeneration. In addition, Ma et al.105 recently designed and


fabricated Fe-CaSiO3 composite scaffolds (30CS) by the 3DP technique for synergistic tumor treatment and bone regeneration (Fig. 8a). In these smart composite scaffolds, four unique


functionalities contributed to tumor therapy and remarkable bone regeneration results. First, in the intrinsically acidic tumor microenvironment, the loaded Fe-containing component could


serve as a Fenton reaction nanocatalyst to trigger the decomposition of H2O2, thus causing the death of cancer cells (Fig. 8b, c). Second, the novel scaffolds exhibited excellent


photothermal effects, elevating the tumor temperature under NIR irradiation. This effect also synergistically strengthened the catalytic Fenton reaction to promote ROS production. Third,


these scaffolds possessed high compressive strength, providing sufficient mechanical support for new bone formation. Finally, these novel scaffolds could support the adhesion, proliferation,


and differentiation of rBMSCs, thus enhancing bone regeneration in vivo (Fig. 8d). Therefore, these novel smart stimuli-responsive scaffolds are promising for the treatment of bone tumors


and the regeneration of bone defects resulting from surgery. In addition to broad application in the field of tumor therapy, multiresponsive strategies also show broad prospects for


application in other fields. Recently, Zhou et al.77 fabricated a novel PPy-PDA-HA film by uniformly and alternately coating PPy-PDA NPs and HA NPs onto the scaffold (Fig. 7). This rational


design endows the scaffold with osteoinductivity, electroactivity, antioxidative activity, and cell affinity. By responding to the excessive ROS generated by inflammation, the PPy-PDA NPs


exhibited long-term antioxidative capacity to protect cells from injury. After electrical stimulation, the PPy-PDA NPs transmitted this stimulus to the cells adhering to the surface and


improved cell proliferation. The synergistic effect of HA and electrical stimulation promoted osteogenic cell differentiation and exhibited remarkable bone regeneration results. Despite the


encouraging results of multiresponsive synergistic therapy, several issues still exist to address in the future. First, the existing smart multiresponsive biomaterials still combine varied


strategies without adequate synergy of the fundamental mechanisms. Thus, the clinical application requirements and the relevant therapeutic mechanisms should be fully considered when


designing a multiresponsive scaffold in the future. In addition, due to the complex structures and multiple compositions of smart multiresponsive biomaterials, the development of precise and


convenient manufacturing processes would also be necessary in the future. CONCLUSION AND FUTURE PROSPECTS Herein, we have summarized and discussed various strategies applied in constructing


unique bifunctional biomaterials for bone disease therapy and bone tissue regeneration. External physical triggers (e.g., magnetic and electric fields, ultrasound, light irradiation or


appropriate mechanical stimulation) or endogenous disease microenvironments (e.g., excess ROS, mild acidity, endogenous electric fields, the immune microenvironment, specific ionic or enzyme


concentrations) can be applied in the construction of smart stimuli-responsive biomaterials to achieve better therapeutic and regeneration targets. The features, advantages, and


disadvantages of different responsive strategies are summarized in Table 1. After the short-term and efficient treatment of severe infection, residual tumor tissue, or other bone diseases, a


therapeutic biomaterial should facilitate cell adhesion, and smart stimuli-responsive materials will thus release bioactive components or osteogenic-related elements to accelerate cell


proliferation and differentiation. All these factors ultimately enhance bone regeneration.21 These novel biomaterials could play a vital role in precise and efficient bone disease therapy


and bone tissue regeneration in the future (Fig. 12). Despite the favorable outcomes of previous work, smart stimuli-responsive materials are still in the preliminary stage with several


challenges and concerns to be addressed in future research: * (1) Since these are newly synthesized biomaterials, their immune responses, metabolic pathways, and biological distribution have


not been systematically explored. Multifunctional biomaterials are loaded with multiple components to implement both therapeutic and regenerative functions, making it arduous to evaluate


biosafety thoroughly. In addition to the potential long-term toxicity, the strength, toughness, and other physical or chemical properties also need to be compared with those of


state-of-the-art biomaterials to enable future clinical translation. * (2) An appropriate biodegradation rate of novel biomaterials with multiple components is also necessary for clinical


translation. After the biosafety, biocompatibility, and biodegradation of these biomaterials are fully assessed, they can ultimately be applied clinically. * (3) The construction of more


novel multifunctional materials that rationally integrate different therapeutic modalities and regenerative materials is still of great importance. The reported smart stimuli-responsive


materials are still limited to certain specific modalities, such as photothermal ablation, magnetic hyperthermia, SDT, and nanocatalytic therapy. In addition to these treatment models, novel


biomaterials fabricated in the future could incorporate various NPs to improve bone regeneration efficiency and deliver drugs or related genes in a controllable mode for precise bone


disease therapeutics. The synthesis of composite material systems utilizing newly developed therapeutic nanoplatforms and biomaterial platforms will continue to be the main direction of


future research. * (4) Owing to the complex fabrication processes of smart stimuli-responsive materials, the exploitation of facile synthetic methodologies to replace the existing complex


synthetic procedures is indispensable. To endow these smart stimuli-responsive materials with multiple functions, researchers integrate various components into one biomaterial platform,


which is implemented by several difficult procedures. To address this crucial issue, the exploitation of facile integrated methodologies is essential. * (5) Various strategies, such as


external stimuli-responsive or internal microenvironment stimuli-responsive approaches, have pros and cons in practical biomedical applications. The effects of the existing newly synthesized


biomaterials in bone therapy and regeneration still cannot be precisely and rationally controlled. Specifically, the precise confirmation of optimum parameters for external stimuli and the


rapid recognition of internal environmental changes are still difficult. Only by determining the optimum parameters, such as the depth and intensity of infrared light, can these novel


strategies be finally applied in the clinic. Thus, this aspect is a definite long-term research focus. * (6) The specific mechanisms of smart stimuli-responsive materials remain to be


investigated in detail, requiring the selection of appropriate animal models for mechanistic studies and performance assessments. Therefore, the selection of appropriate animal models and


further mechanistic exploration are still of great importance for promoting the clinical applications of these novel biomaterials with both bone therapy and tissue regeneration functions. In


conclusion, smart multifunctional stimuli-responsive materials have been explored to some extent and have received considerable attention in antibiotic therapy, tumor therapy, the


prevention of inflammation, and the stimulation of tissue repair. Although some challenges still exist and there is a long way to go for clinical translation, it is expected that smart


stimuli-responsive materials will have profound biomedical applications in the future. REFERENCES * Zhang, Y. et al. Advancements in hydrogel-based drug sustained release systems for bone


tissue engineering. _Front. Pharmacol._ 11, 622 (2020). Article  CAS  PubMed  PubMed Central  Google Scholar  * Wang, P. et al. Bone tissue engineering via nanostructured calcium phosphate


biomaterials and stem cells. _Bone Res._ 2, 14017 (2014). Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhang, K. et al. Advanced smart biomaterials and constructs for hard tissue


engineering and regeneration. _Bone Res._ 6, 31 (2018). Article  PubMed  PubMed Central  Google Scholar  * Dang, M., Saunders, L., Niu, X., Fan, Y. & Ma, P. X. Biomimetic delivery of


signals for bone tissue engineering. _Bone Res._ 6, 25 (2018). Article  PubMed  PubMed Central  Google Scholar  * Sun, W. et al. Injectable nano-structured silicon-containing hydroxyapatite


microspheres with enhanced osteogenic differentiation and angiogenic factor expression. _Ceram. Int._ 44, 20457–20464 (2018). Article  CAS  Google Scholar  * Shang, F. et al. Advancing


application of mesenchymal stem cell-based bone tissue regeneration. _Bioact. Mater._ 6, 666–683 (2021). Article  CAS  PubMed  Google Scholar  * Turnbull, G. et al. 3D bioactive composite


scaffolds for bone tissue engineering. _Bioact. Mater._ 3, 278–314 (2018). Article  PubMed  Google Scholar  * Leppik, L. et al. Combining electrical stimulation and tissue engineering to


treat large bone defects in a rat model. _Sci. Rep._ 8, 6307 (2018). Article  PubMed  PubMed Central  Google Scholar  * Mallick, S. et al. Strategies towards orthopaedic tissue engineered


graft generation: current scenario and application. _Biotechnol. Bioproc. E._ 24, 854–869 (2019). Article  CAS  Google Scholar  * Eivazzadeh‐Keihan, R. et al. Metal‐based nanoparticles for


bone tissue engineering. _J. Tissue Eng. Regen. M._ 14, 1687–1714 (2020). Article  Google Scholar  * Nikolova, M. P. & Chavali, M. S. Recent advances in biomaterials for 3D scaffolds: a


review. _Bioact. Mater._ 4, 271–292 (2019). Article  PubMed  PubMed Central  Google Scholar  * Islam, M. M., Shahruzzaman, M., Biswas, S., Nurus Sakib, M. & Rashid, T. U. Chitosan based


bioactive materials in tissue engineering applications–a review. _Bioact. Mater._ 5, 164–183 (2020). Article  PubMed  PubMed Central  Google Scholar  * Wang, C. et al. 3D printing of bone


tissue engineering scaffolds. _Bioact. Mater._ 5, 82–91 (2020). Article  PubMed  PubMed Central  Google Scholar  * Sadowska, J. M. & Ginebra, M. P. Inflammation and biomaterials: role of


the immune response in bone regeneration by synthetic bone grafts. _J. Mater. Chem. B_ 8, 9404–9427 (2020). Article  CAS  PubMed  Google Scholar  * Lin, K. et al. Enhanced osteoporotic bone


regeneration by strontium-substituted calcium silicate bioactive ceramics. _Biomaterials_ 34, 10028–10042 (2013). Article  CAS  PubMed  Google Scholar  * Wang, C. et al. Strontium released


bi-lineage scaffolds with immunomodulatory properties induce a pro-regenerative environment for osteochondral regeneration. _Mat. Sci. Eng. C._ 103, 109833 (2019). Article  CAS  Google


Scholar  * Marsh, A. C. et al. Fabrication and multiscale characterization of 3D silver containing bioactive glass-ceramic scaffolds. _Bioact. Mater._ 4, 215–223 (2019). Article  PubMed 


PubMed Central  Google Scholar  * Yi, H., Ur Rehman, F., Zhao, C., Liu, B. & He, N. Recent advances in nano scaffolds for bone repair. _Bone Res._ 4, 16050 (2016). Article  CAS  PubMed 


PubMed Central  Google Scholar  * Xuzhu, W. et al. Near-infrared light-triggered drug delivery system based on black phosphorus for invivo bone regeneration. _Biomaterials_ 179, 164–174


(2018). Article  Google Scholar  * Jiang, W. et al. Bioinspired tissue-compliant hydrogels with multifunctions for synergistic surgery–photothermal therapy. _J. Mater. Chem. B_ 8,


10117–10125 (2020). Article  CAS  PubMed  Google Scholar  * Liu, Y., Yu, Q., Chang, J. & Wu, C. Nanobiomaterials: from 0D to 3D for tumor therapy and tissue regeneration. _Nanoscale_ 11,


13678–13708 (2019). Article  CAS  PubMed  Google Scholar  * Chen, B. et al. Advanced theragenerative biomaterials with therapeutic and regeneration multifunctionality. _Adv. Funct. Mater._


30, 2002621 (2020). Article  CAS  Google Scholar  * Chen, J. et al. Palladium nanocrystals-engineered metal–organic frameworks for enhanced tumor inhibition by synergistic


hydrogen/photodynamic therapy. _Adv. Funct. Mater._ 31, 2006853 (2021). Article  CAS  Google Scholar  * Dong, S., Chen, Y., Yu, L., Lin, K. & Wang, X. Magnetic hyperthermia–synergistic


H2O2 self-sufficient catalytic suppression of osteosarcoma with enhanced bone-regeneration bioactivity by 3D-printing composite scaffolds. _Adv. Funct. Mater._ 30, 1907071 (2020). Article 


CAS  Google Scholar  * Jin, X. et al. Self-adaptive antibacterial porous implants with sustainable responses for infected bone defect therapy. _Adv. Funct. Mater._ 29, 1807915 (2019).


Article  Google Scholar  * Deng, Y., Shi, X., Chen, Y., Yang, W. & Chen, Z. G. Bacteria-triggered pH-responsive osteopotentiating coating on 3D-printed polyetheretherketone scaffolds for


infective bone defect repair. _Ind. Eng. Chem. Res._ 59, 12123–12135 (2020). Article  CAS  Google Scholar  * Pourhajibagher, M., Rokn, A. R., Barikani, H. R. & Bahador, A.


Photo-sonodynamic antimicrobial chemotherapy via chitosan nanoparticles-indocyanine green against polymicrobial periopathogenic biofilms: ex vivo study on dental implants. _Photodiagn.


Photodyn._ 31, 101834 (2020). Article  CAS  Google Scholar  * Liu, Y. et al. Built‐in electric fields dramatically induce enhancement of osseointegration. _Adv. Funct. Mater._ 27, 173771


(2017). Article  Google Scholar  * Lui, Y. S., Sow, W. T., Tan, L. P., Wu, Y. & Li, H. 4D printing and stimuli-responsive materials in biomedical aspects. _Acta Biomater._ 92, 19–36


(2019). Article  CAS  PubMed  Google Scholar  * Du, Y., Guo, J. L., Wang, J., Mikos, A. G. & Zhang, S. Hierarchically designed bone scaffolds: from internal cues to external stimuli.


_Biomaterials_ 218, 119334 (2019). Article  CAS  PubMed  PubMed Central  Google Scholar  * Su, K., Tan, L., Liu, X., Cui, Z. & Wu, S. Rapid photo-sonotherapy for clinical treatment of


bacterial infected bone implants by creating oxygen deficiency using sulfur doping. _ACS Nano_ 14, 2077–2089 (2020). Article  CAS  PubMed  Google Scholar  * Jain, A. K. & Jain, S.


Instrumented stabilization in spinal tuberculosis. _Int. Orthop._ 36, 285–292 (2012). Article  PubMed  Google Scholar  * Hu, J., Zhang, G. & Liu, S. Enzyme-responsive polymeric


assemblies, nanoparticles and hydrogels. _Chem. Soc. Rev._ 41, 5933 (2012). Article  CAS  PubMed  Google Scholar  * Chen, J. et al. Biodegradable hollow mesoporous organosilica-based


nanosystems with dual stimuli-responsive drug delivery for efficient tumor inhibition by synergistic chemo- and photothermal therapy. _Appl. Mater. Today_ 19, 100655 (2020). Article  Google


Scholar  * Safari, J. & Zarnegar, Z. Advanced drug delivery systems: nanotechnology of health design—a review. _J. Saudi Chem. Soc._ 18, 85–99 (2014). Article  CAS  Google Scholar  *


Zeng, Y., Hoque, J. & Varghese, S. Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair. _Acta Biomater._ 93, 152–168 (2019). Article  CAS  PubMed  PubMed


Central  Google Scholar  * Montoya, C. et al. On the road to smart biomaterials for bone research: definitions, concepts, advances, and outlook. _Bone Res._ 9, 12 (2021). Article  CAS 


PubMed  PubMed Central  Google Scholar  * Kumar, S. et al. Nanotechnology-based biomaterials for orthopaedic applications: recent advances and future prospects. _Mat. Sci. Eng. C._ 106,


110154 (2020). Article  CAS  Google Scholar  * Fu, Q. et al. Stimuli-responsive plasmonic assemblies and their biomedical applications. _Nano Today_ 36, 101014 (2021). Article  CAS  PubMed 


Google Scholar  * Jin, A., Wang, Y., Lin, K. & Jiang, L. Nanoparticles modified by polydopamine: working as “drug” carriers. _Bioact. Mater._ 5, 522–541 (2020). Article  PubMed  PubMed


Central  Google Scholar  * Dong, S., Wang, X., Shen, G., Wang, X. & Kai, L. Research progress on functional modifications and applications of bioceramic scaffolds. _J. Inorg. Mater._ 35,


867–881 (2020). Article  Google Scholar  * Zhang, H., Fan, T., Chen, W., Li, Y. & Wang, B. Recent advances of two-dimensional materials in smart drug delivery nano-systems. _Bioact.


Mater._ 5, 1071–1086 (2020). Article  PubMed  PubMed Central  Google Scholar  * Escudero, J. S. B., Perez, M. G. B., Rosso, M. P. D. O., Buchaim, D. V. & Buchaim, R. L.


Photobiomodulation therapy (PBMT) in bone repair: a systematic review. _Injury_ 50, 1853–1867 (2019). Article  PubMed  Google Scholar  * Liao, J., Han, R., Wu, Y. & Qian, Z. Review of a


new bone tumor therapy strategy based on bifunctional biomaterials. _Bone Res._ 9, 18 (2021). Article  PubMed  PubMed Central  Google Scholar  * Dang, W. et al. LaB6 surface


chemistry-reinforced scaffolds for treating bone tumors and bone defects. _Appl. Mater. Today_ 16, 42–55 (2019). Article  Google Scholar  * Shen, A. et al. Adhesive graphene grown on


bioceramics with photothermal property. _Mater. Today Chem._ 17, 100322 (2020). Article  CAS  Google Scholar  * Yang, B. et al. 2D-black-phosphorus-reinforced 3D-printed scaffolds: a


stepwise countermeasure for osteosarcoma. _Adv. Mater._ 30, 1705611 (2018). Article  Google Scholar  * Zhao, P. P. et al. Ordered arrangement of hydrated GdPO4 nanorods in magnetic chitosan


matrix promotes tumor photothermal therapy and bone regeneration against breast cancer bone metastases. _Chem. Eng. J._ 381, 122694 (2020). Article  CAS  Google Scholar  * Dong, S. et al. A


novel multifunctional carbon aerogel-coated platform for osteosarcoma therapy and enhanced bone regeneration. _J. Mater. Chem. B_ 8, 368–379 (2020). Article  CAS  PubMed  Google Scholar  *


Zhao, C., Shen, A., Zhang, L., Lin, K. & Wang, X. Borocarbonitrides nanosheets engineered 3D-printed scaffolds for integrated strategy of osteosarcoma therapy and bone regeneration.


_Chem. Eng. J._ 401, 125989 (2020). Article  CAS  Google Scholar  * An, D. et al. Progress in the therapeutic applications of polymer-decorated black phosphorus and black phosphorus analog


nanomaterials in biomedicine. _J. Mater. Chem. B_ 8, 7076–7120 (2020). Article  CAS  PubMed  Google Scholar  * Lin, C., Hao, H., Mei, L. & Wu, M. Metal-free two-dimensional


nanomaterial-mediated photothermal tumor therapy. _Smart Mater. Med._ 1, 150–167 (2020). Article  Google Scholar  * Fu, S., Hu, H., Chen, J., Zhu, Y. & Zhao, S. Silicone resin derived


larnite/C scaffolds via 3D printing for potential tumor therapy and bone regeneration. _Chem. Eng. J._ 382, 122928 (2020). Article  CAS  Google Scholar  * Tonga, L., Liaoa, Q., Zhaoa, Y.,


Huanga, H. & Gaoa, A. Near-infrared light control of bone regeneration with biodegradable photothermal osteoimplant. _Biomaterials_ 193, 1–11 (2019). Article  Google Scholar  * Ma, L. et


al. A novel photothermally controlled multifunctional scaffold for clinical treatment of osteosarcoma and tissue regeneration. _Mater. Today_ 36, 48–62 (2020). Article  CAS  Google Scholar


  * Zeng, J. et al. A novel biocompatible PDA/IR820/DAP coating for antibiotic/photodynamic/photothermal triple therapy to inhibit and eliminate _Staphylococcus aureus_ biofilm. _Chem. Eng.


J._ 394, 125017 (2020). Article  CAS  Google Scholar  * Cao, Z. et al. Effect of nanoheat stimulation mediated by magnetic nanocomposite hydrogel on the osteogenic differentiation of


mesenchymal stem cells. _Sci. China Life Sci._ 61, 448–456 (2018). Article  CAS  PubMed  Google Scholar  * Zhu, Y. et al. Magnetic mesoporous bioactive glass scaffolds: preparation,


physicochemistry and biological properties. _J. Mater. Chem. B._ 1, 1279–1288 (2013). Article  CAS  PubMed  Google Scholar  * Zhang, J. et al. 3D-printed magnetic Fe3O4/MBG/PCL composite


scaffolds with multifunctionality of bone regeneration, local anticancer drug delivery and hyperthermia. _J. Mater. Chem. B._ 2, 7583–7595 (2014). Article  CAS  PubMed  Google Scholar  * Wu,


C. et al. Multifunctional magnetic mesoporous bioactive glass scaffolds with a hierarchical pore structure. _Acta Biomat._ 7, 3563–3572 (2011). Article  CAS  Google Scholar  * Yan, F. et


al. Biphasic injectable bone cement with Fe3O4/GO nanocomposites for the minimally invasive treatment of tumor-induced bone destruction. _ACS Biomater. Sci. Eng._ 5, 5833–5843 (2019).


Article  CAS  PubMed  Google Scholar  * Sun, D., Zhang, Z., Chen, M., Zhang, Y. & Chen, M. Co-immobilization of Ce6 sono/photosensitizer and protonated graphitic-carbon nitride on


PCL/gelation fibrous scaffolds for combined sono-photodynamic cancer therapy. _ACS Appl. Mater. Inter._ 12, 40728–40739 (2020). Article  CAS  Google Scholar  * Fan, B. et al. Electroactive


barium titanate coated titanium scaffold improves osteogenesis and osseointegration with low-intensity pulsed ultrasound for large segmental bone defects. _Bioact. Mater._ 5, 1087–1101


(2020). Article  PubMed  PubMed Central  Google Scholar  * Moonga, S. S. & Qin, Y. X. MC3T3 infiltration and proliferation in bovine trabecular scaffold regulated by dynamic flow


bioreactor and augmented by low-intensity pulsed ultrasound. _J. Orthop. Transl._ 14, 16–22 (2018). Google Scholar  * Ouyang, L. et al. Graphene-oxide-decorated microporous


polyetheretherketone with superior antibacterial capability and in vitro osteogenesis for orthopedic Iimplant. _Macromol. Biosci._ 18, 1800036 (2018). Article  Google Scholar  * Crasto, G.


J. et al. Controlled bone formation using ultrasound-triggered release of BMP-2 from liposomes. _J. Control. Release_ 10, 99–108 (2016). Article  Google Scholar  * Leppik, L., Oliveira, K.


M. C., Bhavsar, M. B. & Barker, J. H. Electrical stimulation in bone tissue engineering treatments. _Eur. J. Trauma Emerg. S._ 46, 231–244 (2020). Article  Google Scholar  * Aleem, I. S.


et al. Efficacy of electrical stimulators for bone healing: a meta-analysis of randomized sham-controlled trials. _Sci. Rep._ 6, 31724 (2016). Article  CAS  PubMed  PubMed Central  Google


Scholar  * Zhao, C., Lin, K. & Wang, X. Maintenance and modulation of stem cells stemness based on biomaterial designing via chemical and physical signals. _Appl. Mater. Today_ 19,


100614 (2020). Article  Google Scholar  * Ferrigno, B. et al. Bioactive polymeric materials and electrical stimulation strategies for musculoskeletal tissue repair and regeneration. _Bioact.


Mater._ 5, 468–485 (2020). Article  PubMed  PubMed Central  Google Scholar  * Balint, R., Cassidy, N. J. & Cartmell, S. H. Conductive polymers: towards a smart biomaterial for tissue


engineering. _Acta Biomater._ 10, 2341–2353 (2014). Article  CAS  PubMed  Google Scholar  * Wang, K., Parekh, U., Ting, J. K., Yamamoto, N. A. D. & Ng, T. N. A platform to study the


effects of electrical stimulation on immune cell activation during wound healing. _Adv. Biosyst._ 3, 1900106 (2019). Article  Google Scholar  * Yan, H. et al. An electrically and


magnetically responsive nanocomposite of GdPO4·H2O/P3HT/PLGA with electrical stimulation for synergistically enhancing the proliferation and differentiation of pre-osteoblasts. _N. J. Chem._


43, 17315–17326 (2019). Article  CAS  Google Scholar  * Deng, Z. et al. Stimuli-responsive conductive nanocomposite hydrogels with high stretchability, self-healing, adhesiveness, and 3D


printability for human motion sensing. _ACS Appl. Mater. Inter._ 11, 6796–6808 (2019). Article  CAS  Google Scholar  * Kapat, K., Shubhra, Q. T. H., Zhou, M. & Leeuwenburgh, S.


Piezoelectric nano‐biomaterials for biomedicine and tissue regeneration. _Adv. Funct. Mater._ 30, 1909045 (2020). Article  CAS  Google Scholar  * Zhu, B. et al. Promotion of the osteogenic


activity of an antibacterial polyaniline coating by electrical stimulation. _Biomater. Sci._ 7, 4730–4737 (2019). Article  CAS  PubMed  Google Scholar  * Zhou, T. et al. A mussel-inspired


persistent ROS-scavenging, electroactive, and osteoinductive scaffold based on electrochemical-driven in situ nanoassembly. _Small_ 15, 1805440 (2019). Article  Google Scholar  * Kim, D. et


al. Biomolecular piezoelectric materials: from amino acids to living tissues. _Adv. Mater._ 32, 1906989 (2020). Article  CAS  Google Scholar  * Ribeiro, C. et al. In vivo demonstration of


the suitability of piezoelectric stimuli for bone reparation. _Mater. Lett._ 209, 118–121 (2017). Article  CAS  Google Scholar  * Przekora, A. Current trends in fabrication of biomaterials


for bone and cartilage regeneration: materials modifications and biophysical stimulations. _Inter. J. Mol. Sci._ 20, 435 (2019). Article  Google Scholar  * Kohata, K. et al. Enhancement of


fracture healing by electrical stimulation in the comminuted intraarticular fracture of distal radius. _Bio-med. Mater. Eng._ 23, 485–493 (2013). Article  Google Scholar  * Reis, J. et al. A


new piezoelectric actuator induces bone formation in vivo: a preliminary study. _J. Biomed. Biotechnol._ 2012, 613403 (2012). Article  PubMed  PubMed Central  Google Scholar  * Jacob, J.,


More, N., Kalia, K. & Kapusetti, G. Piezoelectric smart biomaterials for bone and cartilage tissue engineering. _Inflamm. Regen._ 38, 2 (2018). Article  PubMed  PubMed Central  Google


Scholar  * Khare, D., Basu, B. & Dubey, A. K. Electrical stimulation and piezoelectric biomaterials for bone tissue engineering applications. _Biomaterials_ 258, 120280 (2020). CAS 


PubMed  Google Scholar  * Tang, Y. et al. Fabrication and in vitro biological properties of piezoelectric bioceramics for bone regeneration. _Sci. Rep._ 7, 43360 (2017). Article  PubMed 


PubMed Central  Google Scholar  * Bai, Y. et al. Biomimetic piezoelectric nanocomposite membranes synergistically enhance osteogenesis of deproteinized bovine bone grafts. _Int. J. Nanomed._


14, 3015–3026 (2019). Article  CAS  Google Scholar  * Zhao, F. et al. Periosteum structure/function-mimicking bioactive scaffolds with piezoelectric/chem/nano signals for critical-sized


bone regeneration. _Chem. Eng. J._ 402, 126203 (2020). Article  CAS  Google Scholar  * Frith, J. E. et al. Mechanically-sensitive miRNAs bias human mesenchymal stem cell fate via mTOR


signalling. _Nat. Commun._ 9, 257 (2018). Article  PubMed  PubMed Central  Google Scholar  * Tschumperlin, D. J., Liu, F. & Tager, A. M. Biomechanical regulation of mesenchymal cell


function. _Curr. Opin. Rheumatol._ 25, 92–100 (2013). Article  PubMed  PubMed Central  Google Scholar  * Weyts, F. A. A., Bosmans, B., Niesing, R., Leeuwen, J. P. T. M. & Weinans, H.


Mechanical control of human osteoblast apoptosis and proliferation in relation to differentiation. _Calcif. Tissue Int._ 72, 505–512 (2003). Article  CAS  PubMed  Google Scholar  * Ahdjoudj,


S., Lasmoles, F., Holy, X., Zerath, E. & Marie, P. J. Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. _J.


Bone Miner. Res._ 17, 668–677 (2010). Article  Google Scholar  * Duncan, R. L. & Turner, C. H. Mechanotransduction and the functional response of bone to mechanical strain. _Calcif.


Tissue Int._ 57, 344–358 (1995). Article  CAS  PubMed  Google Scholar  * Panciera, T., Azzolin, L., Cordenonsi, M. & Piccolo, S. Mechanobiology of YAP and TAZ in physiology and disease.


_Nat. Rev. Mol. Cell Bio._ 18, 758–770 (2017). Article  CAS  Google Scholar  * Ouyang, N. et al. Mechanical strain promotes osteogenic differentiation of bone mesenchymal stem cells from


ovariectomized rats via the phosphoinositide 3-kinase/Akt signaling pathway. _Mol. Med. Rep._ 17, 1855–1862 (2018). CAS  PubMed  Google Scholar  * Eichholz, K. F. et al. Human bone marrow


stem/stromal cell osteogenesis is regulated via mechanically activated osteocyte-derived extracellular vesicles. _Stem Cell. Transl. Med._ 9, 1431–1447 (2020). Article  CAS  Google Scholar 


* Puwanun, S. et al. A simple rocker-induced mechanical stimulus upregulates mineralization by human osteoprogenitor cells in fibrous scaffolds. _J. Tissue Eng. Regen. Med._ 12, 370–381


(2018). Article  CAS  PubMed  Google Scholar  * Mohanraj, B. et al. Mechanically-activated microcapsules for ‘on-demand’ drug delivery in dynamically loaded musculoskeletal tissues. _Adv.


Funct. Mater._ 29, 1807909 (2019). Article  PubMed  PubMed Central  Google Scholar  * Hung, B. P., Hutton, D. L. & Grayson, W. L. Mechanical control of tissue-engineered bone. _Stem Cell


Res. Ther._ 4, 1–7 (2013). Article  Google Scholar  * Tuan, H. S., & Hutmacher, D. W. Application of micro CT and computation modeling in bone tissue engineering. _Comput. Aided Des._


37, 1151–1161 (2005). Article  Google Scholar  * Hayyan, M., Hashim, M. A. & Alnashef, I. M. Superoxide ion: generation and chemical implications. _Chem. Rev._ 116, 3029–3085 (2017).


Article  Google Scholar  * Jiang, S., Lin, K. & Cai, M. ZnO nanomaterials: current advancements in antibacterial mechanisms and applications. _Front. Chem._ 8, 580 (2020). Article  CAS 


PubMed  PubMed Central  Google Scholar  * Sun, C. et al. ROS-initiated chemiluminescence-driven payload release from macrocycle-based Azo-containing polymer nanocapsules. _J. Mater. Chem. B_


8, 8878–8883 (2020). Article  CAS  PubMed  Google Scholar  * Wang, X. et al. Polydopamine nanoparticles as dual-task platform for osteoarthritis therapy: a scavenger for reactive oxygen


species and regulator for cellular powerhouses. _Chem. Eng. J._ 417, 129284 (2021). Article  CAS  Google Scholar  * Wang, D. et al. Butyrate-inserted Ni–Ti layered double hydroxide film for


H2O2-mediated tumor and bacteria killing. _Mater. Today_ 20, 238–257 (2017). Article  CAS  Google Scholar  * Ma, H. et al. 3D printing of high-strength bioscaffolds for the synergistic


treatment of bone cancer. _Npg Asia Mater._ 10, 31 (2018). Article  CAS  Google Scholar  * Zhang, J., Liu, L., Wang, L., Zhu, W. & Wang, H. pH responsive zwitterionic-to-cationic


transition for safe self-defensive antibacterial application. _J. Mater. Chem. B_ 8, 8908–8913 (2020). Article  CAS  PubMed  Google Scholar  * Li, K. et al. Calcium-mineralized polypeptide


nanoparticle for intracellular drug delivery in osteosarcoma chemotherapy. _Bioact. Mater._ 5, 721–731 (2020). Article  PubMed  PubMed Central  Google Scholar  * Gisbert-Garzarán, M. &


Vallet-Regí Mesoporous silica nanoparticles for the treatment of complex bone diseases: bone cancer, bone infection and osteoporosis. _Pharmaceutics_ 12, 83 (2020). Article  PubMed Central 


Google Scholar  * Chen, H. et al. Cartilage-targeting and dual MMP-13/pH responsive theranostic nanoprobes for osteoarthritis imaging and precision therapy. _Biomaterials_ 225, 119520


(2019). Article  CAS  PubMed  Google Scholar  * Jin, T. et al. Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy


against knee osteoarthritis. _J. Nanobiotechnol._ 18, 94 (2020). Article  CAS  Google Scholar  * Lin, X. et al. Smart nanosacrificial layer on the bone surface prevents osteoporosis through


acid-base neutralization regulated biocascade effects. _J. Am. Chem. Soc._ 142, 17543–17556 (2020). Article  CAS  PubMed  Google Scholar  * Zhang, X. et al. Nanocomposite membranes enhance


bone regeneration through restoring physiological electric microenvironment. _ACS Nano_ 10, 7279–7286 (2016). Article  CAS  PubMed  Google Scholar  * Lu, Y., Aimetti, A. A., Langer, R. &


Gu, Z. Bioresponsive materials. _Nat. Rev. Mater._ 2, 16075 (2016). Article  Google Scholar  * Krishna, A. S., Radhakumary, C. & Sreenivasan, K. Calcium ion modulates protein release


from chitosan-hyaluronic acid poly electrolyte gel. _Polym. Eng. Sci._ 55, 2089–2097 (2015). Article  CAS  Google Scholar  * Tan, L. L. et al. Ca2+, pH and thermo triple-responsive


mechanized Zr-based MOFs for on-command drug release in bone diseases. _J. Mater. Chem. B_ 4, 135–140 (2015). Article  PubMed  Google Scholar  * Galuska, S. P., Geyer, R., Gerardy-Schahn,


R., Mühlenhoff, M. & Geyer, H. Enzyme-dependent variations in the polysialylation of the neural cell adhesion molecule (NCAM) in vivo. _J. Biol. Chem._ 283, 17–28 (2008). Article  CAS 


PubMed  Google Scholar  * Qu, M. et al. Stimuli-responsive delivery of growth factors for tissue engineering. _Adv. Healthc. Mater._ 9, e1901714 (2020). Article  PubMed  PubMed Central 


Google Scholar  * Paiva, K. B. S. & Granjeiro, J. M. Bone tissue remodeling and development: focus on matrix metalloproteinase functions. _Arch. Biochem. Biophys._ 561, 74–87 (2014).


Article  CAS  PubMed  Google Scholar  * Zhang, W., Ouyang, H., Dass, C. R. & Xu, J. Current research on pharmacologic and regenerative therapies for osteoarthritis. _Bone Res._ 4, 15040


(2016). Article  CAS  PubMed  PubMed Central  Google Scholar  * Hu, Q., Katti, P. S. & Gu, Z. Enzyme-responsive nanomaterials for controlled drug delivery. _Nanoscale_ 6, 12273–12286


(2014). Article  CAS  PubMed  PubMed Central  Google Scholar  * Arrighi, I. et al. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. _Biomaterials_ 30,


1763–1771 (2009). Article  CAS  PubMed  Google Scholar  * Patterson, J. & Hubbell, J. A. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and


MMP-2. _Biomaterials_ 31, 7836–7845 (2010). Article  CAS  PubMed  Google Scholar  * Li, N. et al. An enzyme-responsive membrane for antibiotic drug release and local periodontal treatment.


_Colloid Surf. B_ 183, 110454 (2019). Article  CAS  Google Scholar  * Holloway, J. L., Ma, H., Rai, R. & Burdick, J. A. Modulating hydrogel crosslink density and degradation to control


bone morphogenetic protein delivery and in vivo bone formation. _J. Control. Release_ 191, 63–70 (2014). Article  CAS  PubMed  PubMed Central  Google Scholar  * Anjum, F. et al. Enzyme


responsive GAG-based natural-synthetic hybrid hydrogel for tunable growth factor delivery and stem cell differentiation. _Biomaterials_ 87, 104–117 (2016). Article  CAS  PubMed  Google


Scholar  * Ding, Y. et al. A dual-functional implant with an enzyme-responsive effect for bacterial infection therapy and tissue regeneration. _Biomater. Sci._ 8, 1840–1854 (2020). Article 


CAS  PubMed  Google Scholar  * Qi, H. et al. Systemic administration of enzyme-responsive growth factor nanocapsules for promoting bone repair. _Biomater. Sci._ 7, 1675–1685 (2019). Article


  CAS  PubMed  Google Scholar  * Lee, J., Byun, H., Madhurakkat Perikamana, S. K., Lee, S. & Shin, H. Current advances in immunomodulatory biomaterials for bone regeneration. _Adv.


Healthc. Mater._ 8, 1801106 (2019). Google Scholar  * Liu, L. et al. The synergistic promotion of osseointegration by nanostructure design and silicon substitution of hydroxyapatite coatings


in a diabetic model. _J. Mater. Chem. B_ 8, 2754 (2020). Article  CAS  PubMed  Google Scholar  * Zhang, X., Cui, J., Cheng, L. & Lin, K. Enhancement of osteoporotic bone regeneration by


strontium-substituted 45S5 bioglass via time-dependent modulation of autophagy and the Akt/mTOR signaling pathway. _J. Mater. Chem. B_ 9, 3489 (2021). Article  CAS  PubMed  Google Scholar 


* Yin, X., Zhou, C., Li, J., Liu, R. & Shi, B. Autophagy in bone homeostasis and the onset of osteoporosis. _Bone Res._ 7, 16–31 (2019). Article  Google Scholar  * Sang, W., Zhang, Z.,


Dai, Y. & Chen, X. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. _Chem. Soc. Rev._ 48, 3771–3810 (2019). Article  PubMed  Google Scholar  * Chen, Z.


et al. Osteoimmunomodulation for the development of advanced bone biomaterials. _Mater. Today_ 19, 304–321 (2016). Article  CAS  Google Scholar  * Loi, F. et al. Inflammation, fracture and


bone repair. _Bone_ 86, 119–130 (2016). Article  CAS  PubMed  PubMed Central  Google Scholar  * Schmidt-Bleek, K. et al. Initial immune reaction and angiogenesis in bone healing. _J. Tissue


Eng. Regen. M._ 8, 120–130 (2014). Article  CAS  Google Scholar  * Niu, Y., Wang, Z., Shi, Y., Dong, L. & Wang, C. Modulating macrophage activities to promote endogenous bone


regeneration: biological mechanisms and engineering approaches. _Bioact. Mater._ 6, 244–261 (2021). Article  CAS  PubMed  Google Scholar  * Liu, R. et al. Immunomodulation-based strategy for


improving soft tissue and metal implant integration and its implications in the development of metal soft tissue materials. _Adv. Funct. Mater._ 30, 1910672 (2020). Article  CAS  Google


Scholar  * Freytes, D. O., Kang, J. W., Marcos-Campos, I. & Vunjak-Novakovic, G. Macrophages modulate the viability and growth of human mesenchymal stem cells. _J. Cell. Biochem._ 114,


220–229 (2013). Article  CAS  PubMed  Google Scholar  * Koh, T. J. & DiPietro, L. A. Inflammation and wound healing: the role of the macrophage. _Expert Rev. Mol. Med._ 13, e23 (2011).


Article  PubMed  PubMed Central  Google Scholar  * Bastidas-Coral, A. P. et al. IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells. _J.


Cell. Physiol._ 234, 20520–20532 (2019). Article  CAS  PubMed  PubMed Central  Google Scholar  * Giorgio, M., Patrizia, D., Roberta, F. & Giacomina, B. The interplay between the bone and


the immune system. _Clin. Dev. Immunol._ 2013, 720504 (2013). Google Scholar  * Chen, L. et al. Multi-faceted effects of mesenchymal stem cells (MSCs) determined by immune microenvironment


and their implications on MSC/biomaterial-based inflammatory disease therapy. _Appl. Mater. Today_ 18, 100485 (2020). Article  Google Scholar  * Xie, Y. et al. Osteoimmunomodulatory effects


of biomaterial modification strategies on macrophage polarization and bone regeneration. _Regen. Biomater._ 7, 233–245 (2020). Article  CAS  PubMed  PubMed Central  Google Scholar  * Ou, Q.


et al. Nanosilver-incorporated halloysite nanotubes/gelatin methacrylate hybrid hydrogel with osteoimmunomodulatory and antibacterial activity for bone regeneration. _Chem. Eng. J._ 382,


123019 (2020). Article  CAS  Google Scholar  * Sadowska, J. M. & Ginebra, M. P. Inflammation and biomaterials: role of the immune response in bone regeneration by inorganic scaffolds.


_J. Mater. Chem. B_ 8, 9404–9427 (2020). Article  CAS  PubMed  Google Scholar  * Lourenco, A. H. et al. Osteogenic, anti-osteoclastogenic and immunomodulatory properties of a


strontium-releasing hybrid scaffold for bone repair. _Mat. Sci. Eng. C._ 99, 1289–1303 (2019). Article  CAS  Google Scholar  * Tsukasaki, M. & Takayanagi, H. Osteoimmunology: evolving


concepts in bone-immune interactions in health and disease. _Nat. Rev. Immunol._ 19, 626–642 (2019). Article  CAS  PubMed  Google Scholar  * Ota, Y. et al. Generation mechanism of RANKL+


effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis. _Arthritis Res. Ther._ 18, 67 (2016). Article  PubMed  PubMed Central  Google Scholar  * Garash, R., Bajpai,


A., Marcinkiewicz, B. M. & Spiller, K. L. Drug delivery strategies to control macrophages for tissue repair and regeneration. _Exp. Biol. Med._ 241, 1054–1063 (2016). Article  CAS 


Google Scholar  * Zhou, P. et al. Calcium silicate bioactive ceramics induce osteogenesis through oncostatin M. _Bioact. Mater._ 6, 810–822 (2021). Article  CAS  PubMed  Google Scholar  *


Chen, Z. et al. Osteoimmunomodulatory properties of magnesium scaffolds coated with beta-tricalcium phosphate. _Biomaterials_ 35, 8553–8565 (2014). Article  CAS  PubMed  Google Scholar  *


Lin, J. et al. Gd@C82(OH)22 harnesses inflammatory regeneration for osteogenesis of mesenchymal stem cells through JNK/STAT3 signaling pathway. _J. Mater. Chem. B_ 6, 5802–5811 (2018).


Article  CAS  PubMed  Google Scholar  * Yang, C. et al. Stimulation of osteogenesis and angiogenesis by micro/nano hierarchical hydroxyapatite via macrophage immunomodulation. _Nanoscale_


11, 17699–17708 (2019). Article  CAS  PubMed  Google Scholar  * Jia, X. et al. EZH1 is associated with TCP-induced bone regeneration through macrophage polarization. _Stem. Cells Int._ 2018,


6310560 (2018). Article  PubMed  PubMed Central  Google Scholar  * Hu, Z., Ma, C., Rong, X., Zou, S. & Liu, X. Immunomodulatory ECM-like microspheres for accelerated bone regeneration


in diabetes mellitus. _ACS Appl. Mater. Inter._ 10, 2377–2390 (2018). Article  CAS  Google Scholar  * Li, M. et al. Controllable release of interleukin-4 in double-layer sol–gel coatings on


TiO2 nanotubes for modulating macrophage polarization. _Biomed. Mater._ 13, 045008 (2018). Article  PubMed  Google Scholar  * He, C., Yu, L., Yao, H., Chen, Y. & Hao, Y. Combinatorial


photothermal 3D-printing scaffold and checkpoint blockade inhibits growth/metastasis of breast cancer to bone and accelerates osteogenesis. _Adv. Funct. Mater._ 31, 2006214 (2021). Article 


CAS  Google Scholar  * Kim, J., Kim, J., Jeong, C. & Kim, W. J. Synergistic nanomedicine by combined gene and photothermal therapy. _Adv. Drug Deliv. Rev._ 98, 99–112 (2016). Article 


CAS  PubMed  Google Scholar  * Lu, J. W., Yang, F., Ke, Q. F., Xie, X. T. & Guo, Y. P. Magnetic nanoparticles modified-porous scaffolds for bone regeneration and photothermal therapy


against tumors. _Nanomed-nanotechnol._ 14, 811–822 (2018). Article  CAS  Google Scholar  * Rodrigues, A. F. M. et al. Effective production of multifunctional magnetic-sensitive biomaterial


by an extrusion-based additive manufacturing technique. _Biomed. Mater._ 16, 015011 (2021). Article  CAS  Google Scholar  * Mushtaq, A. et al. Magnetic hydroxyapatite nanocomposites: the


advances from synthesis to biomedical applications. _Mater. Des._ 197, 109269 (2021). Article  CAS  Google Scholar  * Ribeiro, C., Correia, D. M., Ribeiro, S., Fernandes, M. M. &


Lanceros-Mendez, S. Piezo- and magnetoelectric polymers as biomaterials for novel tissue engineering strategies. _MRS Adv._ 3, 1–6 (2018). Article  Google Scholar  Download references


FUNDING This work was funded by the National Natural Science Foundation of China (82072396, 81871490, 81771047, 82071096), Double Hundred Plan (20191819), Program of Shanghai


Academic/Technology Research Leader (19XD1434500, 20XD1433100), Science and Technology Commission of Shanghai Municipality (21490711700), the Interdisciplinary Program of Shanghai Jiao Tong


University (YG2021ZD12), Shanghai Collaborative Innovation Center for Translational Medicine (TM202010), and Open Project of State Key Laboratory of Oral Diseases (SKLOD2021OF01). AUTHOR


INFORMATION Author notes * These authors contributed equally: Hongpu Wei, Jinjie Cui. AUTHORS AND AFFILIATIONS * Department of Oral & Cranio-Maxillofacial Surgery, Shanghai Ninth


People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology &


Shanghai Research Institute of Stomatology, Shanghai, 200011, China Hongpu Wei, Jinjie Cui, Kaili Lin & Xudong Wang * State Key Laboratory of Oral Diseases, West China Hospital of


Stomatology, Sichuan University, Chengdu, 610041, China Jing Xie Authors * Hongpu Wei View author publications You can also search for this author inPubMed Google Scholar * Jinjie Cui View


author publications You can also search for this author inPubMed Google Scholar * Kaili Lin View author publications You can also search for this author inPubMed Google Scholar * Jing Xie


View author publications You can also search for this author inPubMed Google Scholar * Xudong Wang View author publications You can also search for this author inPubMed Google Scholar


CONTRIBUTIONS H.W. and J.C. wrote the manuscript. J.X., K.L., and X.W. conceived the concept of this review. All authors discussed and commented on the manuscript. CORRESPONDING AUTHORS


Correspondence to Kaili Lin, Jing Xie or Xudong Wang. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. SUPPLEMENTARY INFORMATION RESPONSE TO REVIEWER


LICENSES FOR THE CITED FIGS. 2–11 RIGHTS AND PERMISSIONS OPEN ACCESS This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing,


adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons


license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a


credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted


use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissions ABOUT


THIS ARTICLE CITE THIS ARTICLE Wei, H., Cui, J., Lin, K. _et al._ Recent advances in smart stimuli-responsive biomaterials for bone therapeutics and regeneration. _Bone Res_ 10, 17 (2022).


https://doi.org/10.1038/s41413-021-00180-y Download citation * Received: 07 February 2021 * Revised: 26 July 2021 * Accepted: 17 September 2021 * Published: 23 February 2022 * DOI:


https://doi.org/10.1038/s41413-021-00180-y SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative